TORONTO, June 22, 2022 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) (“Field Trip”), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for its fiscal fourth quarter and full year ended March 31, 2022, after market close on Wednesday, June 29, 2022. The Company will conduct a conference…


Previous articleCOMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting
Next articleSmall Pharma to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022